As of 2025-12-14, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 70.11 USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.51 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 73.1%.
The range of the Relative Valuation is 45.26 - 99.50 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.0x - 24.7x | 17.6x |
| Forward P/E multiples | 26.4x - 37.1x | 31.0x |
| Fair Price | 45.26 - 99.50 | 70.11 |
| Upside | 11.7% - 145.6% | 73.1% |
| Date | P/E |
| 2025-12-12 | 12.57 |
| 2025-12-11 | 12.28 |
| 2025-12-10 | 12.18 |
| 2025-12-09 | 12.04 |
| 2025-12-08 | 12.07 |
| 2025-12-05 | 12.36 |
| 2025-12-04 | 11.87 |
| 2025-12-03 | 11.48 |
| 2025-12-02 | 11.17 |
| 2025-12-01 | 11.02 |
| 2025-11-28 | 10.95 |
| 2025-11-26 | 11.03 |
| 2025-11-25 | 10.96 |
| 2025-11-24 | 10.94 |
| 2025-11-21 | 10.64 |
| 2025-11-20 | 10.36 |
| 2025-11-19 | 10.33 |
| 2025-11-18 | 10.54 |
| 2025-11-17 | 10.54 |
| 2025-11-14 | 10.56 |
| 2025-11-13 | 10.64 |
| 2025-11-12 | 10.40 |
| 2025-11-11 | 10.23 |
| 2025-11-10 | 9.87 |
| 2025-11-07 | 9.75 |
| 2025-11-06 | 9.60 |
| 2025-11-05 | 9.73 |
| 2025-11-04 | 9.53 |
| 2025-11-03 | 9.10 |
| 2025-10-31 | 8.86 |
| 2025-10-30 | 8.97 |
| 2025-10-29 | 9.10 |
| 2025-10-28 | 9.19 |
| 2025-10-27 | 9.34 |
| 2025-10-24 | 9.38 |
| 2025-10-23 | 9.18 |
| 2025-10-22 | 8.15 |
| 2025-10-21 | 8.12 |
| 2025-10-20 | 8.07 |
| 2025-10-17 | 8.03 |
| 2025-10-16 | 8.05 |
| 2025-10-15 | 8.26 |
| 2025-10-14 | 8.33 |
| 2025-10-13 | 8.18 |
| 2025-10-10 | 8.23 |
| 2025-10-09 | 8.31 |
| 2025-10-08 | 8.24 |
| 2025-10-07 | 8.39 |
| 2025-10-06 | 8.25 |
| 2025-10-03 | 8.46 |